Seagen Inc.
NASDAQ: SGEN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David R. Epstein
- Employees
- 3,256
- Headquarters
- Bothell, United States
- IPO year
- 2001
- Market cap
- $43.2B
- Website
- https://www.seagen.com
Loading SGEN…
Loading profile data…Frequently asked questions about SGEN
What does Seagen Inc. (SGEN) do?
Seagen Inc. is a biotechnology firm focused on the development and global commercialization of innovative cancer treatments. Its portfolio features several key oncology therapeutics, including ADCETRIS, an antibody-drug conjugate (ADC) utilized for Hodgkin lymphoma and CD30-positive T-cell lymphomas; PADCEV, another ADC designed to target Nectin...
Where does SGEN trade?
Seagen Inc. (SGEN) trades on the NASDAQ Global Select.
What sector is SGEN in?
Seagen Inc. (SGEN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Seagen Inc.?
David R. Epstein is the chief executive officer of Seagen Inc. (SGEN).
Where is Seagen Inc. headquartered?
Seagen Inc. is headquartered in United States.
Does SGEN pay a dividend?
Seagen Inc. (SGEN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SGEN go public?
Seagen Inc. (SGEN) completed its initial public offering in 2001.